Aquatic Capital Management LLC Macrogenics Inc Transaction History

Aquatic Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $55,082 - $95,526	18,300 Added 571.88%	21,500 $74,000
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $6,075 - $26,973	2,700 Added 540.0%	3,200 $9,000
Q1 2022 May 16, 2022	BUY	$8.12 - $16.9 $1,623 - $3,379	200 Added 66.67%	500 $4,000
Q4 2021 Feb 14, 2022	BUY	$15.91 - $21.88 $4,773 - $6,564	300 New	300 $5,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $202M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.